BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 18514908)

  • 1. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services.
    Sirois FM
    Complement Ther Med; 2008 Apr; 16(2):73-80. PubMed ID: 18514908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use among health plan members. A cross-sectional survey.
    Gray CM; Tan AW; Pronk NP; O'Connor PJ
    Eff Clin Pract; 2002; 5(1):17-22. PubMed ID: 11878283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of complementary alternative medicine (CAM) use.
    Al-Windi A
    Complement Ther Med; 2004; 12(2-3):99-111. PubMed ID: 15561519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of complementary and alternative medicine use in chronic pain patients.
    Ndao-Brumblay SK; Green CR
    Pain Med; 2010 Jan; 11(1):16-24. PubMed ID: 20447293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland--an observational study.
    Busato A; Dönges A; Herren S; Widmer M; Marian F
    Fam Pract; 2006 Feb; 23(1):116-24. PubMed ID: 16115833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
    Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
    Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.
    Mao JJ; Farrar JT; Xie SX; Bowman MA; Armstrong K
    Complement Ther Med; 2007 Mar; 15(1):21-9. PubMed ID: 17352968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study.
    Miller MF; Bellizzi KM; Sufian M; Ambs AH; Goldstein MS; Ballard-Barbash R
    J Am Diet Assoc; 2008 Mar; 108(3):483-94. PubMed ID: 18313431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of complementary medicinal therapies in West Pomerania: a population-based study.
    Schwarz S; Messerschmidt H; Völzke H; Hoffmann W; Lucht M; Dören M
    Climacteric; 2008 Apr; 11(2):124-34. PubMed ID: 18365855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: results from a nationwide canadian survey.
    Fautrel B; Adam V; St-Pierre Y; Joseph L; Clarke AE; Penrod JR
    J Rheumatol; 2002 Nov; 29(11):2435-41. PubMed ID: 12415605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical skepticism and the use of complementary and alternative health care providers by patients followed by rheumatologists.
    Callahan LF; Freburger JK; Mielenz TJ; Wiley-Exley EK
    J Clin Rheumatol; 2008 Jun; 14(3):143-7. PubMed ID: 18525432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health service use amongst users of complementary and alternative medicine.
    Pledger MJ; Cumming JN; Burnette M
    N Z Med J; 2010 Apr; 123(1312):26-35. PubMed ID: 20389315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine in Israel: 2000 vs. 1993.
    Shmueli A; Shuval J
    Isr Med Assoc J; 2004 Jan; 6(1):3-8. PubMed ID: 14740500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary and alternative medicine by older patients with arthritis: a population-based study.
    Kaboli PJ; Doebbeling BN; Saag KG; Rosenthal GE
    Arthritis Rheum; 2001 Aug; 45(4):398-403. PubMed ID: 11501729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
    Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
    Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
    Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary and alternative medicine practitioners by people with physical disabilities: estimates from a National US Survey.
    Carlson MJ; Krahn G
    Disabil Rehabil; 2006 Apr; 28(8):505-13. PubMed ID: 16513583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.